Recent Company News

• 02:06 AM ET Oct 01, 2025
  

  Renalytix submits application for CE Mark certification to enable clinical use and reporting of kidneyintelX.dk test across EU (9.5000p, 0)

• 04:00 AM ET Sep 16, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 02:43 AM ET Sep 26, 2025
  

  StreetAccount Summary - EU equity offerings recap, week of 22-Sep

• 02:02 AM ET Sep 26, 2025
  

  Renalytix PLC announces £7.05M total gross proceeds from Fundraise (10.0000p, 0)

• 09:02 AM ET Sep 24, 2025
  

  Renalytix clarifies that forward revenue guidance provided does not include full consideration of implications of recently announced collaboration with Tempus AI, Inc. (8.7500p, -0.1)

• 02:09 AM ET Sep 23, 2025
  

  Renalytix releases corporate presentation that includes revised guidance: expected revenue $8.4M in FY26 vs prior $8.5M, $19.0M in FY27 vs prior $17.5M (10.0000p, 0)

• 02:10 AM ET Sep 22, 2025
  

  Renalytix to raise a minimum of £4.0M gross proceeds through placing and subscription and additional £0.5M through a Retail Offer (10.7500p, 0)